The antiatherogenic effect of high density lipoprotein (HDL) has been attrib uted to either an inhibition of cholesterol uptake or to reversed cholesterol transport from peripheral cells. In order to determine whether HDL competi tively blocks receptor-mediated low density lipoprotein (LDL) binding and up take, bovine aortic enothelial cells (BAECs) were cultured in Dulbecco's modified Eagles Medium (DMEM) containing 10% LDL-free fetal bovine serum, and incubated with 125I-LDL in concentrations of either 10 or 25 μg protein/mL. Varying amounts of HDL (0-200 μg/mL) were added to the media. Following a twenty-four hour incubation period at 37°C, 125I-LDL binding and uptake were measured.
At the lower concentration of 125I-LDL, which represents high-affinity recep tor binding, there was no significant difference in either binding or uptake within the range of HDL concentrations studied. At the higher concentration of LDL, however, there was a marked inhibition of 125I-LDL binding (p<.006) and uptake (p<,001; ANOVA), which did not saturate at the highest HDL concentrations used. These data suggest that HDL does not influence high-affinity, receptor-me diated binding and uptake of LDL but that its effect is seen at a concentration of LDL representing nonspecific binding. The lack of saturation at increasing concentrations of HDL also indicates that HDL-receptor interaction is not essen tial for the effect.
Get full access to this article
View all access options for this article.
References
1.
Miller GJ, Miller NE: Plasma-high-density lipoprotein concentration and the development of ischaemic heart disease. Lancet1:16-19, 1975.
2.
Catelli WP, Doyle JT, Gordon T., et al: HDL cholesterol and other lipids in coronary heart deisease. The co-operative lipoprotein phenotyping study. Circulation55:767-72, 1977.
3.
Gordon T., Castelli WP, Hjortland MG, et al: High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med62:707-14, 1977.
4.
Miller NE, Forde OH, Thelle D., et al: High-density lipoprotein and coronary heart disease: A prospective case-control study. Lancet1:985-988, 1977.
5.
Miller NE, Weinstein DB, Carew TE, et al: Interactions beteen high density and low density lipoproteins during uptake and degradation by cultured human fibroblasts. J Clin Invest60:78-88, 1977.
6.
Carew TE, Koschinsky T., Hayes SB, et al: A mechanism by which high-density lipoproteins may slow the atherogenic process. Lancet1:1315-1317, 1976.
7.
Glomset JA: Physiological role of lecithin-cholesterol acyltransferase. Am J Clin Nutr23:1129-36, 1970.
8.
Rothblat RH, Guertler LS, Parker TS, et al: Studies on the rate of efflux of cholesterol from cultured human skin fibroblasts. J Biol Chem256:4978-4983, 1981.
9.
Stein O., Vanderheok J., Stein Y.: Cholesterol content and sterol synthesis in human skin fibroblasts and rat aortic smooth muscle cells exposed to lipoprotein-depleted serum and high density apolipoprotein/phospholipid mixtures. Biochem Biophys Acta341:347-358, 1986.
10.
Fredrickson DS, Levy RI, Lees RS: Fat transport in lipoproteins—an integrated approach to mechanisms and disorders. N Engl J Med276:34-33, 1967.
11.
Goldstein JL , Brown MS: The low-density Lipoprotein pathway and its relation to atherosclerosis. Ann Rev Biochem46:897-930, 1977.
12.
Brown MS, Goldstein JL: Familial hyperscholesterolemia: Defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxyl-3-methylglutaryl coenzyme A reductase activity. Proc Natl Acad Sci71:788-792, 1974.
13.
Booyse FM, Sedlak BJ, Rafelson ME, Jr: Culture of arterial endothelial cells. Characterization and growth of bovine aortic cells. Throm Diath Haemorrh34:825-839, 1975.
14.
Havel RJ, Eder HA, Bragdon JH: The distribution and chemical composition of altracentrifugally separated lipoproteins in humn serum. J Clin Invest34:1345-1353, 1955.
15.
Markwell MA : A new solid state reagent to iodinate proteins . Anal Biochem125:427-432, 1982.
16.
Lowry OH, Rosebrough NJ, Farr AL, et al: Protein measurement with the folin phenol reagent. J Biol Chem193:265-275, 1951.
17.
Goldstein JL , Basusk, Brunschede GY, et al: Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans . Cell7:85-95, 1976.
18.
Biesbroeck R., Oram JF, Albers JJ: Specific high-affinity binding of high density lipoproteins to cultured human skin fibroblasts and arterial smooth muscle cells. J Clin Invest71:525-539, 1983.
19.
Sniderman AD , Carew TE, Chandler JG: Paradoxical increase in rate of catabolism of low-density lipoproteins after hepatectomy. Science183:526-528, 1974.
20.
Weinstein DB , Carew TE, Steinberg D.: Uptake and degradation of low- density liprotein by swine arterial smooth muscle cells with inhibition of cholesterol biosynthesis . Biochem Biophys Acta424:404-421, 1976.
21.
Tall AR, Small DM: Body cholesterol removal: Role of high-density lipoproteins. Adv Lipid Res17:1-51, 1980.
22.
Oram JF, Johnson CJ, Brown TA: Interaction of high density lipoprotein with its recepto on cultured fibroblasts and macrophages. J Biol Chem262:2405-2410. 1987.
23.
Miller NE, Weinstein DB, Steinberg D.: Binding, internalization, and degradation of high density lipoprotein by cultured normal human fibroblasts. J Lipid Res18:438-450, 1977.
24.
Miller NE: Induction of low density lipoprotein receptor synthesis by high density lipoprotein in cultures of human skin fibroblasts. Biochem Biophys Acta529:131-137,1978.
